Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.

2.50
Hdl Handle:
http://hdl.handle.net/10541/88044
Title:
Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.
Authors:
Burt, E C; James, Louise A; Greaves, Martin J; Birch, Jillian M; Boyle, John M; Varley, Jennifer
Abstract:
Studies of Li-Fraumeni syndrome fibroblasts heterozygous for germline TP53 mutations have shown that loss of heterozygosity (LOH) occurs during passaging and is associated with genomic instability, such as chromosomal aberrations and aneuploidy to investigate the genomic changes associated with LOH in Li-Fraumeni (LF) fibroblasts, we have analysed cell strains at increasing population doublings (PD) using Comparative Genomic Hybridization (CGH). We have looked at three groups of cell strains: LF mutation-carrying strains which showed LOH for TP53, LF mutation-carrying strains which did not show LOH, and strains from normal individuals. Using CGH, we have detected loss of distinct chromosomal regions associated with LOH in 4 out of 5 mutation-carrying strains. In particular we have found loss of chromosomal regions containing genes involved in cell cycle control or senescence, including loss of 9p and 17p in these strains. Other recurrent changes included loss of chromosomes 4q and 6q, regions shown to contain one or more tumour suppressor genes. No genomic alterations were detected at cumulative PD in the normal strains or in the LF mutation-carrying strains which did not show LOH for TP53. We have also analysed the three groups of strains for microsatellite instability and somatic TP53 mutations, and have found genetic alterations in only one strain.
Affiliation:
CRC Cancer Genetics Group, Patterson Institute for Cancer Research, Manchester.
Citation:
Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts. 2000, 83 (4):467-72 Br. J. Cancer
Journal:
British Journal of Cancer
Issue Date:
Aug-2000
URI:
http://hdl.handle.net/10541/88044
DOI:
10.1054/bjoc.2000.1292
PubMed ID:
10945493
Type:
Article
Language:
en
ISSN:
0007-0920
Appears in Collections:
All Paterson Institute for Cancer Research

Full metadata record

DC FieldValue Language
dc.contributor.authorBurt, E Cen
dc.contributor.authorJames, Louise Aen
dc.contributor.authorGreaves, Martin Jen
dc.contributor.authorBirch, Jillian Men
dc.contributor.authorBoyle, John Men
dc.contributor.authorVarley, Jenniferen
dc.date.accessioned2009-12-15T17:11:25Z-
dc.date.available2009-12-15T17:11:25Z-
dc.date.issued2000-08-
dc.identifier.citationGenomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts. 2000, 83 (4):467-72 Br. J. Canceren
dc.identifier.issn0007-0920-
dc.identifier.pmid10945493-
dc.identifier.doi10.1054/bjoc.2000.1292-
dc.identifier.urihttp://hdl.handle.net/10541/88044-
dc.description.abstractStudies of Li-Fraumeni syndrome fibroblasts heterozygous for germline TP53 mutations have shown that loss of heterozygosity (LOH) occurs during passaging and is associated with genomic instability, such as chromosomal aberrations and aneuploidy to investigate the genomic changes associated with LOH in Li-Fraumeni (LF) fibroblasts, we have analysed cell strains at increasing population doublings (PD) using Comparative Genomic Hybridization (CGH). We have looked at three groups of cell strains: LF mutation-carrying strains which showed LOH for TP53, LF mutation-carrying strains which did not show LOH, and strains from normal individuals. Using CGH, we have detected loss of distinct chromosomal regions associated with LOH in 4 out of 5 mutation-carrying strains. In particular we have found loss of chromosomal regions containing genes involved in cell cycle control or senescence, including loss of 9p and 17p in these strains. Other recurrent changes included loss of chromosomes 4q and 6q, regions shown to contain one or more tumour suppressor genes. No genomic alterations were detected at cumulative PD in the normal strains or in the LF mutation-carrying strains which did not show LOH for TP53. We have also analysed the three groups of strains for microsatellite instability and somatic TP53 mutations, and have found genetic alterations in only one strain.en
dc.language.isoenen
dc.subject.meshCells, Cultured-
dc.subject.meshChromosome Deletion-
dc.subject.meshFibroblasts-
dc.subject.meshGenes, p53-
dc.subject.meshGerm-Line Mutation-
dc.subject.meshHumans-
dc.subject.meshLi-Fraumeni Syndrome-
dc.subject.meshLoss of Heterozygosity-
dc.subject.meshMicrosatellite Repeats-
dc.subject.meshNucleic Acid Hybridization-
dc.titleGenomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.en
dc.typeArticleen
dc.contributor.departmentCRC Cancer Genetics Group, Patterson Institute for Cancer Research, Manchester.en
dc.identifier.journalBritish Journal of Canceren

Related articles on PubMed

All Items in Christie are protected by copyright, with all rights reserved, unless otherwise indicated.